Calidi Biotherapeutics (CLDWW) Q4 2025 Earnings

Nov 13Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-2.21
-1.69
-1.17
-0.65

Details

Expected EPS
-1.68
Actual EPS
-2.21
Surprise EPS
-0.53
Surprise Percent
-31.55%

Description

⁨Calidi Biotherapeutics⁩ (⁦CLDWW⁩) has reported earnings of ⁦-2.21⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts